Veracyte (VCYT) Announces New General Manager Structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- Nasdaq drags on Wall St as AI slowdown fears hammer Nvidia, chipmakers
- Global AI stocks fall as industry chiefs call for slowing development
- Oil prices continue surge, rising 3% as attacks halt Saudi pipeline
- BofA sees just 2% upside for the S&P 500 over the next 12 months
- Wall Street's new pair trade: Long software, short chips
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Veracyte Announces New General Manager Structure to Advance Global Expansion
November 17, 2020 8:30 AM ESTJohn Hanna appointed GM, endocrinology, breast cancer and lymphoma;
Morten Frost to join company as GM, pulmonology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte (Nasdaq: VCYT) today announced a new general manager-based structure to advance the companys growing roster of genomic tests and its global expansion.... More
